Core Viewpoint - Guangzhou is advancing its biopharmaceutical industry by establishing four major value parks and releasing the first national biopharmaceutical industry map, aiming to create a 400 billion yuan industry cluster by 2030 [1][2]. Group 1: Development Strategy - Guangzhou focuses on transforming achievements and manufacturing, creating a comprehensive development path of "selecting tracks + building parks + attracting projects + matching elements" [1]. - The establishment of the four parks marks a shift from "single-point breakthroughs" to "systematic reconstruction" in the biopharmaceutical industry [2]. Group 2: Park Functions and Features - Huangpu International Biopharmaceutical Value Park (2475 acres) focuses on R&D incubation and large-scale production, aiming to become a leading biopharmaceutical base in Asia [3]. - Nansha Life and Health Value Park (2236 acres) leverages cross-border policies to focus on "innovative drug and device R&D + life health manufacturing" [3]. - Yuexiu Clinical Technology Achievement Transformation Park (700,000 square meters) aims to facilitate medical achievement transformation and market circulation [3]. - Liwan Modern Traditional Chinese Medicine and High-end Medical Device Park (1000 acres) integrates TCM cultural resources and strengthens the modernization of TCM and medical device industry chains [3]. Group 3: Ecosystem and Support - Guangzhou is building a comprehensive ecosystem covering R&D, production, clinical, and distribution, significantly reducing innovation costs [4]. - The city’s development zone generates nearly 100 new drug clinical approvals annually, accounting for over 90% of the city's total [4]. - The government emphasizes the importance of the entire regional industrial ecosystem and application scenarios over mere financial incentives [4]. Group 4: Industry Map and Services - The first national biopharmaceutical industry map provides comprehensive information on policies, space, funding, and service platforms, facilitating quick understanding for enterprises [5]. - The map outlines an "one core, two poles, multiple parks" spatial layout, with Guangzhou Biomedicine Island as the core [5][6]. - It details 305 public service platforms and 61 biopharmaceutical industrial parks, with a total land area of 536.14 hectares and a total building area of 14.6181 million square meters [7].